← Open Payments lookup

NAJMUDDIN KARIMJEE: Open Payments

NPI 1285660241 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,749 in 101 payments from 17 companies in 2025. Trend: 2023 $1,183 · 2024 $2,132 · 2025 $1,749

Food & beverage: $1,749
CompanyPaymentsAmount
ABBVIE INC.50$638
Astellas Pharma US Inc13$258
AstraZeneca Pharmaceuticals LP6$160
Exact Sciences Corporation3$154
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)5$101
Xeris Pharmaceuticals, Inc.3$54
Phathom Pharmaceuticals, Inc.3$53
Mannkind Corporation3$52
Amgen Inc.3$47
Axsome Therapeutics, Inc.2$45

Products named: Veozah, UBRELVY, SYNTHROID, The Cologuard Plus Collection Kit, FARXIGA, VRAYLAR, QULIPTA, CAPLYTA.

Industry payments across TX — which companies pay providers there.